reference/11984709

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11984709

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article
endingPage	72
issn	1021-335X 1791-2431
issueIdentifier	4
pageRange	965-72
publicationName	Oncology Reports
startingPage	965
bibliographicCitation	Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Takamura M, Yano M, Sanpei A, Aoyagi Y, Hatakeyama K, Ajioka Y. Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol Rep. 2010 Apr;23(4):965–72. doi: 10.3892/or_00000721. PMID: 20204280.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64ef3dd9392f6fcec79f4b43c95e69ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fb5d958d81ff2b66715e88c5e76f5b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2da7d44972fa54d7be853122b083e345 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c35361366d37411dd3205d7a4cc551ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b30bef6c5acd2e86a5caafa24c41fa78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3283070e5e3a4cc71b230f583dc126d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b82f2162f6585799e5e9f5bc7614992c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a03257513ed29901688ecc1e04ac0cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27de4d1fd1cd00f91efec94fc77073a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ae72b025408a86143ad5984350e02ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc7eee7ee88fc78488e9e30e9d948521
date	2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3892/or_00000721 https://pubmed.ncbi.nlm.nih.gov/20204280
isPartOf	https://portal.issn.org/resource/ISSN/1791-2431 https://portal.issn.org/resource/ISSN/1021-335X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20608
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0238823 http://id.nlm.nih.gov/mesh/M0304794 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M000744925
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008113Q000235 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D027425Q000235 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D019008Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008113Q000473 http://id.nlm.nih.gov/mesh/D008113Q000188 http://id.nlm.nih.gov/mesh/D000089762 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D027425Q000096 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006528Q000235 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006528Q000188 http://id.nlm.nih.gov/mesh/D006528Q000473 http://id.nlm.nih.gov/mesh/D009336 http://id.nlm.nih.gov/mesh/D010865 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D015153 http://id.nlm.nih.gov/mesh/D007150 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8596 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_27d6f83aa7b1069e4ec36d1661bd979e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1244

Total number of triples: 66.